Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure... Show more
PROF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where PROF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where PROF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on August 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PROF as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
PROF moved below its 50-day moving average on July 25, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PROF crossed bearishly below the 50-day moving average on July 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PROF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PROF entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.278) is normal, around the industry mean (57.379). P/E Ratio (0.000) is within average values for comparable stocks, (37.765). PROF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.644). PROF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (12.240) is also within normal values, averaging (90.474).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PROF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PROF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
a developer and manufacturee of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology
Industry MedicalNursingServices
A.I.dvisor tells us that PROF and MTD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and MTD's prices will move in lockstep.
Ticker / NAME | Correlation To PROF | 1D Price Change % | ||
---|---|---|---|---|
PROF | 100% | -2.29% | ||
MTD - PROF | 28% Poorly correlated | +1.54% | ||
NYXH - PROF | 26% Poorly correlated | -1.07% | ||
A - PROF | 26% Poorly correlated | +0.56% | ||
QTRX - PROF | 24% Poorly correlated | -13.79% | ||
CATX - PROF | 24% Poorly correlated | +1.38% | ||
More |
Ticker / NAME | Correlation To PROF | 1D Price Change % |
---|---|---|
PROF | 100% | -2.29% |
Medical/Nursing Services industry (227 stocks) | 19% Poorly correlated | +0.31% |
Health Services industry (442 stocks) | 10% Poorly correlated | +0.88% |